ITMIG Abstract Submission Opens April 6

The information below outlines key details for abstract submission to the International Thymic Malignancy Interest Group (ITMIG) Annual Meeting. Submitting your work offers a valuable opportunity to share your research, present new ideas, and connect with experts in the field.

Before beginning your proposal, please carefully review the frequently asked questions, important dates, and submission guidelines provided below.

NOTE: Research results or case reports presented during ITMIG2026 should not be published prior to the meeting. If publication occurs after you submit your abstract

to the conference, please CONTACT US immediately.

Please email Pam Bruce at pbruce@thymic.org with any questions.

Abstract Submission Opens

Abstract Submission Closes

Abstract Notifications

Abstract Title Release

Poster PDF Submission Deadline

LALCA ITMIG Conference

April 6, 2026

June 29, 2026

July 13, 2026

October 22, 2026

October 29, 2026

November 12 - 14, 2026

ITMIG Abstract Submission Guidelines
  • General abstract submission requirements:

- Language: English

- Title: No length limit. Please indicate the specific study/article type (e.g. a randomized controlled trial,

- Co-authors: No limit

- Main text (excluding title, authors and keywords): limit 350 words

- Main text construction:

  • ORIGINAL RESEARCH: Background, Methods, Results, Conclusion;
  • STUDY PROTOCOL: Background, Methods, Discussion, Trial Registration;
  • CASE REPORTS: Background, Case Description, Conclusion.

- Images and/or tables: 1 maximum, acceptable formats: JPG, PNG, TIFF, resolution for web images suggested (72 PPI), size limit: 1 MB.

- Keywords: 3 - 5 phrases separated with coma

- Predominant discipline of the abstract should be defined

- Number of abstracts submission: No limits

What types of abstracts can be submitted?
  • Original scientific research
  • Study protocol
  • Case reports (accepted as posters only)
  1. NOTE: Clinical Trials in Progress can be categorized as either "Original Research" or "Study Protocol."
  2. NOTE: Research results or case reports presented during ITMIG2025 should not have been published prior to the meeting. If publication occurs after you submit your abstract to the conference, please CONTACT US immediately.
  3. Important: If your abstract is accepted for oral or poster presentation at the ITMIG Annual Meeting, the editorial office of MEDIASTINUM will contact you for confirmation of the abstract format. Only abstracts approved by the journal's editorial office will be accepted for final publication in the post-conference Abstract Book. Journal requirements for conference abstracts are available HERE.

CONFERENCE ABSTRACTS PUBLISHED IN MEDIASTINUM ARE INDEXED IN PubMed Central (PMC)!

Guidelines for Oral and Poster Presentations

ORAL PRESENTATIONS

- Presentations of abstracts take place live. Online or recorded presentations are not expected.

- Duration: 7 min for presentation + 3 min for discussion.

- PPT format recommended. Presentations will be uploaded on site.

POSTERS

- Poster format to be shared after acceptance.

What languages can I use in my abstract?

Abstracts will be accepted in English only.

Is there a limit to the number of abstracts an author can present?

There is no limit to the number of poster abstracts that an author may present however authors are limited to presenting one (1) oral abstract.

Is there a charge for abstract submission?

No.

Is onsite poster printing available?

No, poster printing services are not coordinated by IASLC / ITMIG.

When will abstracts be available for viewing?

Abstract titles and PDF copies will be released on the program October 29, 2026. Embargoed LBA will be released upon presentation at the conference.